News
COPD Infection Management and Mitigation Strategies: Focusing on Diagnostics and Targeted Treatments
Patients with COPD are at increased risk for infections, making avoidance and effective treatments key in management.
Among adults with undiagnosed respiratory symptoms, those with undiagnosed COPD and asthma vs. preserved ratio impaired or ...
Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state. Understanding this variation could help address public health gaps to ease the burden ...
The FDA approved United Kingdom-based GlaxoSmithKline’s Trelegy Ellipta, a once-daily inhaler that contains three medicines for chronic obstructive pulmonary disease. The inhaler, developed with the ...
Chronic obstructive pulmonary disease, or COPD, is a group of lung diseases with no cure. CNN wellness expert Dr. Leana Wen eyes a new study examining “young COPD.” ...
A recent study reveals that COPD, or Smokers' Disease, is impacting younger individuals. Doctors in Delhi are observing a ...
Merck’s Maurice R. Hilleman Center for Vaccine Manufacturing photographed on Friday, Apr. 2, 2021, in Durham, N.C. Casey Toth [email protected] In one of the biggest health care deals of 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback